Target Professions: DO, MD, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Neurology
Credits Available: 4.00 hours of AMA PRA Category 1 Credit™, MOC Points Available

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a progressive immune-mediated disorder of the peripheral nerves attributed to demyelination and impairment of signal conduction in motor and/or sensory nerves. Symptoms include loss of strength and sensation typically causing symmetrical, proximal, and distal weakness. Disease progression is variable, with many patients experiencing chronic patterns of relapse and remission. This proposed educational initiative establishes impactful small group interactions among highly qualified neurology providers that will, through a variety of collaborative educational experiences, help them optimize the care of their patients with CIDP. This program will include discussions with experts and peers who can share knowledge, real world experiences, strategies, challenges, and success stories.


CME/CE Accreditation Information

Itinerary

Part 1

Baseline Assessment

Answer the questions to gauge your current knowledge of CIDP: diagnosis and workup, evidence for and use of subcutaneous therapies, and use of corticosteroids.

Module 1: ​ CIDP and Other Immune-mediated Polyneuropathies: Differential Diagnosis and Workup

This module reviews the clinical presentation, differential, and workup of CIDP, including separation from GBS and from mimics such as MMN and CIDP variants.

Module 2: ​ Subcutaneous Treatments in CIDP

This module will focus on the diagnosis and treatment of chronic immune-mediated polyneuropathies, with a focus on chronic inflammatory demyelinating polyneuropathy (CIDP).

Module 3: ​ Judicious and Appropriate Use of Corticosteroids

In this module, we will discuss the judicious and appropriate use of corticosteroids in CIDP.

Final Assessment

After completing the modules, answer these questions to assess your mastery of CIDP: diagnosis and workup, evidence for and use of subcutaneous therapies, and use of corticosteroids.

Part 2

Patient Case – 71-year-old Richard

Richard is a 71-year-old man was brought to the emergency department by ambulance after falling during an appointment with his family doctor. He complained of 9 weeks of progressive leg weakness, intermittent lancinating lower back pain, and had fallen tw

Live Group Discussion

In this Live Group Discussion we will review a CIDP case complicated by diabetes, discuss the baseline/final assessments and self-study modules, and finally review an interesting CIDP patient needing medication changes.

Interested in becoming a Group Leader?

Requirements:
Ideal group leaders should be neurologists and neurology APPs (NPs, PAs) involved in the management of patients with CIDP. Apply Now

You cannot sign up as a Group Member because there are no groups available or because you are already signed up.